June 02, 2025
1 min watch
KIAWAH ISLAND, S.C. — Povicaine, launched in late 2024, has “turn into a staple in our apply,” Brandon D. Ayres, MD, stated on this Healio Video Perspective from Kiawah Eye.
Ayres, who practices within the better Philadelphia space at Wills Eye Hospital and Ophthalmic Companions, makes use of Povicaine (povidone-iodine 1.25% and proparacaine 0.5%, ImprimisRx) in procedures comparable to collagen cross-linking, superficial keratectomy, lamellar keratectomy and suture elimination.
“It retains our sufferers snug for longer than they want [to be] for the procedures, and I’m not nervous about infections as a result of we’ve the povidone-iodine already on board,” he stated.
Printed by:
